Insider Trading: Neurocrine Biosciences Inc (NBIX.O)
NBIX.O on Nasdaq
12.01USD
12:12pm EDT
12.01USD
12:12pm EDT
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$11.75
$11.75
Open
$12.06
$12.06
Day's High
$12.12
$12.12
Day's Low
$11.71
$11.71
Volume
275,801
275,801
Avg. Vol
521,100
521,100
52-wk High
$12.85
$12.85
52-wk Low
$6.25
$6.25
| BVF PARTNERS L P | Options Exercised: 0 | ||
| Trade Date: | Sunday, 9 Oct 2011 | Price: | 5.59 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 3,505,400 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | 73,900 |
Institutional Holders
| % Shares Owned: | 85.99% |
| # of Holders: | 144 |
| Total Shares Held: | 57,385,792 |
| 3 Mo. Net Change: | 2,217,747 |
| # New Positions: | 25 |
| # Closed Positions: | 12 |
| # Increased Positions: | 73 |
| # Reduced Positions: | 51 |
| # Net Buyers: | 22 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
William Rastetter |
64 | 2011 | Independent Chairman of the Board |
Kevin Gorman |
54 | 2008 | President, Chief Executive Officer, Director |
Timothy Coughlin |
45 | 2006 | Chief Financial Officer, Vice President |
Haig Bozigian |
54 | 2010 | Senior Vice President - Pharmaceutical and Preclinical Development |
Christopher O'Brien |
55 | Senior Vice President, Chief Medical Officer | |
Dimitri Grigoriadis |
54 | 2007 | Vice President - Research |
Gary Lyons |
62 | 2008 | Independent Director |
W. Thomas Mitchell |
65 | 2002 | Independent Director |
Joseph Mollica |
70 | 2011 | Independent Director |
Corinne Nevinny |
53 | 2004 | Independent Director |
Richard Pops |
50 | 1998 | Independent Director |
Stephen Sherwin |
64 | 1999 | Independent Director |
Jane Sorensen |
Investor Relations Officer |

